TY - JOUR
AU - N. Soliman
AU - V. Kuret
AU - E. Chan
AU - C. Smith
AU - M. A. Thomas
AU - H. Mahallati
AU - H. Grosjean
AU - E. Friebe
AU - L. Rusnell
A1 - 
AB - Unique from other fetal anatomical systems, the central nervous system (CNS) starts development early in the embryonic period shortly after fertilization before most patients are even aware they are pregnant. Maturation throughout pregnancy involve complicated structural and functional changes, most likely below the resolution of testing to detect. During this time, the fetal CNS is susceptible to lesions that reflect trimester-specific adverse events. Neonatal neurological status with childhood sequelae can result from combinations of antenatal, peripartum and neonatal adverse events. Person-specific clinical management choices must consider the timing of multiple mechanisms that can alter neurodevelopment including genetic causes, aetiologies after conception as well as communicable and non-communicable conditions that result in anomalous or destructive brain lesions. The appearance of the fetal brain also changes significantly through gestation as different structures mature and the cerebral cortex in particular increases in size and complexity. Therefore, obstetrical imagers and maternal fetal medicine physicians need to be aware of the expected evolving appearances of the healthy fetal brain as the fetus advances in gestation. Often when fetal CNS pathology is detected or anticipated during pregnancy, there is understandably significant parental anxiety regarding the long-term implications of their child's neurodevelopmental prognosis. In these instances, Maternal Fetal Medicine specialists often collaborate with Pediatric Neurologists in the antenatal period regarding diagnoses that anticipate neonatal or later childhood neurologic sequelae. Potential adverse outcomes are discussed with prospective parents to be integrated into choices based on shared decisions.
AD - Department of Obstetrics and Gynecology, Section of Maternal Fetal Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: Nancy.Soliman@albertahealthservices.ca.; Department of Obstetrics and Gynecology, Section of Maternal Fetal Medicine, University of Calgary, Calgary, AB, Canada.; Department of Anatomical Pathology, University of Calgary, Calgary, AB, Canada.; Department of Medical Genetics and Pediatrics, University of Calgary, Calgary, AB, Canada.; Department of Radiology, University of Calgary, Calgary, AB, Canada.; Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB, Canada.
AN - 39551660
BT - Semin Fetal Neonatal Med
C5 - Education & Workforce; Healthcare Disparities
CP - 4-5
DA - Nov
DO - 10.1016/j.siny.2024.101555
DP - NLM
ET - 20241112
IS - 4-5
JF - Semin Fetal Neonatal Med
LA - eng
N2 - Unique from other fetal anatomical systems, the central nervous system (CNS) starts development early in the embryonic period shortly after fertilization before most patients are even aware they are pregnant. Maturation throughout pregnancy involve complicated structural and functional changes, most likely below the resolution of testing to detect. During this time, the fetal CNS is susceptible to lesions that reflect trimester-specific adverse events. Neonatal neurological status with childhood sequelae can result from combinations of antenatal, peripartum and neonatal adverse events. Person-specific clinical management choices must consider the timing of multiple mechanisms that can alter neurodevelopment including genetic causes, aetiologies after conception as well as communicable and non-communicable conditions that result in anomalous or destructive brain lesions. The appearance of the fetal brain also changes significantly through gestation as different structures mature and the cerebral cortex in particular increases in size and complexity. Therefore, obstetrical imagers and maternal fetal medicine physicians need to be aware of the expected evolving appearances of the healthy fetal brain as the fetus advances in gestation. Often when fetal CNS pathology is detected or anticipated during pregnancy, there is understandably significant parental anxiety regarding the long-term implications of their child's neurodevelopmental prognosis. In these instances, Maternal Fetal Medicine specialists often collaborate with Pediatric Neurologists in the antenatal period regarding diagnoses that anticipate neonatal or later childhood neurologic sequelae. Potential adverse outcomes are discussed with prospective parents to be integrated into choices based on shared decisions.
PY - 2024
SN - 1744-165x
SP - 101555
ST - Overview of reproductive and pregnancy health principles and practice used by maternal-fetal medicine specialists for fetal-neonatal neurology consultants
T1 - Overview of reproductive and pregnancy health principles and practice used by maternal-fetal medicine specialists for fetal-neonatal neurology consultants
T2 - Semin Fetal Neonatal Med
TI - Overview of reproductive and pregnancy health principles and practice used by maternal-fetal medicine specialists for fetal-neonatal neurology consultants
U1 - Education & Workforce; Healthcare Disparities
U3 - 10.1016/j.siny.2024.101555
VL - 29
VO - 1744-165x
Y1 - 2024
ER -